Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

MICROGENDX, LLC

NPI: 1073776860 · LUBBOCK, TX 79413 · Clinical Medical Laboratory · NPI assigned 07/02/2008

$2.11M
Total Medicaid Paid
147,001
Total Claims
103,967
Beneficiaries
34
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialCOLLINS, SHANLEY (BILLING MANAGER)
NPI Enumeration Date07/02/2008

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 25,567 $325K
2019 28,827 $307K
2020 31,683 $576K
2021 29,908 $559K
2022 27,559 $287K
2023 2,385 $49K
2024 1,072 $5K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 6,737 5,955 $448K
87799 25,272 8,928 $238K
87900 7,098 6,189 $218K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 10,319 9,125 $168K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 17,487 4,713 $167K
87640 14,446 12,581 $138K
87653 14,825 12,823 $131K
87500 7,123 6,085 $68K
87482 5,617 4,885 $67K
87481 8,047 6,982 $67K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 416 332 $62K
0112U 3,739 3,413 $53K
87512 4,530 3,858 $53K
87652 5,157 4,467 $47K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 3,248 2,889 $30K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 158 136 $26K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,717 1,385 $21K
87641 2,550 2,098 $20K
87492 1,481 1,237 $18K
87592 1,477 1,227 $17K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1,498 1,253 $16K
87511 1,329 1,121 $11K
87507 26 26 $7K
87581 357 282 $5K
87486 357 282 $5K
81479 Unlisted molecular pathology procedure 1,422 1,190 $3K
87631 34 33 $2K
87563 311 272 $1K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 15 14 $574.84
87634 15 13 $363.98
89051 94 85 $88.40
89060 18 16 $51.97
86140 63 56 $35.91
83872 18 16 $26.84